IRS Logo
Print - Click this link to Print this page

Qualifying Therapeutic Discovery Project Grants for the State of Kansas

The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.

The project descriptions below were extracted from the applicant certification forms as submitted.

Kansas $ 3,818,255.68
Applicant Name Project Name Grants Awarded for 2009 Grants Awarded for 2010
CritiTech, Inc Nanotax®: sustained drug release from pure drug nanoparticles to treat ovarian cancer $ 150,954.50 $ 93,524.74
CritiTech, Inc. Nanothecin™: sustained drug release from pure drug nanoparticles to treat peritoneal cancer $ 133,544.50 $ 110,934.74
CyDex Pharmaceuticals Inc Melphalan HC1 for Injection(Propylene Glycol Free) $ 244,479.24  
CyDex Pharmaceuticals Inc New Dosage Form of Clopidogrel-Rapid Onset Injectable $ 133,059.00 $ 111,420.24
Edenspace Systems Corporation An oral Therapeutic Agent for Ischemic, Inflammatory and Immune Disorders $ 3,316.00 $ 68,826.00
ImmunoGenetix Therapeutics, Inc GeneProTM (4SHIVku2)- a DNA vaccine therapeutic for HIV patients $ 57,552.08 $ 15,420.00
KC BioMedix, Inc Ntrainer System ® $ 244,479.24  
Madeira Therapeutics LLC Novel Analgesic Oral Solution to Treat Pain in Children.   $ 154,500.00
Maderia Therapeutics, LLC Novel Simvastatian Oral Solution to Treat High Cholesterol in Children $ 198,050.00 $ 46,429.24
NanoScale Corporation Functionalized Core/Shell Fe/Fe304 Stealth Nanoparticles for Cancer Diagnosis & Treatment   $ 78,000.00
NanoScale Corporation Intelligent Low-Toxicity Materials for Cancer Diagnosis and Treatment. $ 66,869.00 $ 54,807.46
Nexus Medical, LLC Nexus TKO $ 187,678.50 $ 56,800.75
Oncimmune (USA) LLC EarlyCDT-Lung-a novel blood test to aid in the early detection of cancer $ 244,479.24  
Orbis Biosciences, Inc Precision Particle Fabrication Technology for improving Therapeutics through API Control $ 149,637.14 $ 94,842.10
Pulse NeedleFree Systems, Inc. Multi-Use Needle-Free Injection Device $ 53,817.50 $ 86,917.50
Spinal Simplicity, LLC Minuteman & Scarab Interspinous Process Fusion Cage Devices $ 120,187.78 $ 124,291.47
TVAX Biomedical, LLC TVI-Brain-1 as a Treatment for Malignant Cancer $ 9,183.50 $ 235,295.74
VasoGenix Pharmaceuticals Inc Novel Sustained Treatment of Heart Failure $ 244,479.24  
Verrow Pharmaceuticals Inc Development of a new kidney protective x-ray contrast dye $ 235,199.50 $ 9,279.74

References/Related Topics

Page Last Reviewed or Updated: 05-Aug-2013